In addition, age, β2-microglobulin, LDH, albumin, MRI, and gene risk score were used to construct a nomogram to predict the 1-, 2-, 3-, 4, and 5-year overall survival of MM patients. This evidence concerns the gene HLA-G and Miyoshi myopathy.